What is Stargardt Disease

Stargardt disease is a rare, inherited eye condition that causes progressive vision loss by damaging the macula, the small area in the center of the retina responsible for sharp, central vision. It is primarily caused by mutations in the ABCA4 gene, which leads to the accumulation of toxic fatty deposits in the retinal cells. Currently, 284 people with Stargardt disease have joined the DiseaseMaps community to share their experiences and support one another.

What exactly is Stargardt disease?

Stargardt disease is the most common form of hereditary macular dystrophy. While the condition primarily affects the macula, it generally spares peripheral (side) vision. Unlike age-related macular degeneration, which typically affects older adults, Stargardt disease usually manifests in childhood or adolescence. The condition interferes with the eye's ability to process vitamin A, causing a buildup of a yellowish substance called lipofuscin in the retinal pigment epithelium. Over time, this buildup leads to the death of photoreceptor cells, resulting in blurred or distorted central vision, blind spots, and increased sensitivity to bright light.

What causes Stargardt disease and is it hereditary?

Stargardt disease is almost always caused by mutations in the ABCA4 gene, which is inherited in an autosomal recessive pattern. This means that both parents must carry a copy of the mutated gene to pass it on to their child, even if the parents themselves do not have the condition. In rare cases, mutations in other genes, such as ELOVL4, can cause a slightly different, dominant form of the disease. Because it is genetic, it is a lifelong condition that is present from birth, though symptoms may not appear until later in life.

How common is this condition and who is affected?

Estimates suggest that Stargardt disease affects approximately 1 in 8,000 to 1 in 10,000 people worldwide. Key demographic facts include:

• Age of Onset: Symptoms most commonly appear between the ages of 6 and 20, though some individuals may not experience significant vision changes until their 30s or 40s.


• Gender Distribution: The condition affects both males and females equally.


• Geographic Factors: Stargardt disease is found globally across all ethnic groups, with no specific geographic concentration.

How does Stargardt disease differ from other eye conditions?

It is important to distinguish Stargardt disease from other retinal dystrophies. Unlike Retinitis Pigmentosa, which typically begins with night blindness and a loss of peripheral vision, Stargardt disease focuses its impact on central visual acuity. Patients often retain functional peripheral vision, allowing them to navigate their environment even as their central vision declines. Clinical differentiation often involves specialized imaging, such as fundus autofluorescence, which reveals the characteristic "flecks" of lipofuscin deposits around the macula.

Next steps

• Consult a retina specialist or a neuro-ophthalmologist for a comprehensive dilated eye exam and genetic testing.


• Connect with the 284 members on DiseaseMaps.org to share coping strategies and insights into living with the condition.


• Inquire about low-vision rehabilitation services, which can provide tools to maximize remaining vision.


• Monitor clinical trials via ClinicalTrials.gov, as research into gene therapies and pharmacological interventions for Stargardt disease is ongoing.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Stargardt Disease.


• Orphanet: Stargardt disease (ORPHA:814).


• Online Mendelian Inheritance in Man (OMIM): Stargardt Disease 1; STGD1.


• Foundation Fighting Blindness: Resources and research updates for Stargardt disease.